GB0803948D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0803948D0
GB0803948D0 GBGB0803948.9A GB0803948A GB0803948D0 GB 0803948 D0 GB0803948 D0 GB 0803948D0 GB 0803948 A GB0803948 A GB 0803948A GB 0803948 D0 GB0803948 D0 GB 0803948D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0803948.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HABBAL MAGDI E
Original Assignee
HABBAL MAGDI E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HABBAL MAGDI E filed Critical HABBAL MAGDI E
Priority to GBGB0803948.9A priority Critical patent/GB0803948D0/en
Publication of GB0803948D0 publication Critical patent/GB0803948D0/en
Priority to CN2009801074137A priority patent/CN101998856A/zh
Priority to ES09716524.5T priority patent/ES2507570T3/es
Priority to US12/920,345 priority patent/US10045984B2/en
Priority to EP09716524.5A priority patent/EP2257292B1/en
Priority to PT97165245T priority patent/PT2257292E/pt
Priority to JP2010549109A priority patent/JP5587215B2/ja
Priority to DK09716524.5T priority patent/DK2257292T3/da
Priority to CA2754281A priority patent/CA2754281C/en
Priority to PCT/EP2009/052394 priority patent/WO2009109531A2/en
Priority to CY20141100739T priority patent/CY1115555T1/el
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0803948.9A 2008-03-03 2008-03-03 Combination therapy Ceased GB0803948D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0803948.9A GB0803948D0 (en) 2008-03-03 2008-03-03 Combination therapy
PCT/EP2009/052394 WO2009109531A2 (en) 2008-03-03 2009-02-27 Combination therapy
EP09716524.5A EP2257292B1 (en) 2008-03-03 2009-02-27 Zn/trimethoprim combination therapy
ES09716524.5T ES2507570T3 (es) 2008-03-03 2009-02-27 Terapia de combinación de Zn/trimetoprim
US12/920,345 US10045984B2 (en) 2008-03-03 2009-02-27 Combination therapy
CN2009801074137A CN101998856A (zh) 2008-03-03 2009-02-27 锌/甲氧苄啶结合治疗
PT97165245T PT2257292E (pt) 2008-03-03 2009-02-27 Terapia com uma combinação zn/trimetoprima
JP2010549109A JP5587215B2 (ja) 2008-03-03 2009-02-27 併用療法
DK09716524.5T DK2257292T3 (da) 2008-03-03 2009-02-27 Kombinationsterapi med Zn/trimethoprim
CA2754281A CA2754281C (en) 2008-03-03 2009-02-27 Antiviral combination of zinc and trimethoprim
CY20141100739T CY1115555T1 (el) 2008-03-03 2014-09-11 Συνδυαστικη θεραπεια ζh/τριμεθοπριμης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0803948.9A GB0803948D0 (en) 2008-03-03 2008-03-03 Combination therapy

Publications (1)

Publication Number Publication Date
GB0803948D0 true GB0803948D0 (en) 2008-04-09

Family

ID=39315874

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0803948.9A Ceased GB0803948D0 (en) 2008-03-03 2008-03-03 Combination therapy

Country Status (11)

Country Link
US (1) US10045984B2 (enExample)
EP (1) EP2257292B1 (enExample)
JP (1) JP5587215B2 (enExample)
CN (1) CN101998856A (enExample)
CA (1) CA2754281C (enExample)
CY (1) CY1115555T1 (enExample)
DK (1) DK2257292T3 (enExample)
ES (1) ES2507570T3 (enExample)
GB (1) GB0803948D0 (enExample)
PT (1) PT2257292E (enExample)
WO (1) WO2009109531A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2740657C1 (ru) * 2020-05-15 2021-01-19 Общество С Ограниченной Ответственностью "Промомед Рус" Противовирусная композиция
NL2028566B1 (nl) * 2021-06-29 2023-01-09 Simons Care Innovation Group B V Een zinkzout huidpleister en werkwijzen
JP7287730B2 (ja) * 2021-10-12 2023-06-06 ローバル株式会社 ウイルスを不活化可能な高濃度亜鉛末塗料

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125610A (en) * 1977-07-27 1978-11-14 Bristol-Myers Company Antibacterial compositions
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto

Also Published As

Publication number Publication date
CY1115555T1 (el) 2017-01-04
US20110045070A1 (en) 2011-02-24
EP2257292B1 (en) 2014-07-16
CN101998856A (zh) 2011-03-30
ES2507570T3 (es) 2014-10-15
WO2009109531A3 (en) 2009-11-12
DK2257292T3 (da) 2014-09-29
PT2257292E (pt) 2014-10-22
JP5587215B2 (ja) 2014-09-10
CA2754281C (en) 2016-12-06
EP2257292A2 (en) 2010-12-08
US10045984B2 (en) 2018-08-14
CA2754281A1 (en) 2009-09-11
WO2009109531A2 (en) 2009-09-11
JP2011513356A (ja) 2011-04-28

Similar Documents

Publication Publication Date Title
IL206654A0 (en) Combination therapy
GB0811304D0 (en) Therapeutic agents
GB0823213D0 (en) Treatment
GB0802116D0 (en) Treatment
IL199992A0 (en) Combination therapy
GB0819593D0 (en) Therapeutic agents
GB0822011D0 (en) Treatment
GB0801081D0 (en) Therapeutic agents
GB0821693D0 (en) Therapeutic agents
GB0801080D0 (en) Therapeutic agents
GB0812309D0 (en) Therapeutic agents
GB0719518D0 (en) Therapy
GB0805818D0 (en) Therapeutic agents
GB0811992D0 (en) Treatment
EP2211863A4 (en) COMBINATION THERAPY
GB0700284D0 (en) Combination therapy
GB0803948D0 (en) Combination therapy
GB0916997D0 (en) Combination therapy
GB0820972D0 (en) Treatment
GB0907973D0 (en) Combination therapy
EP2454276A4 (en) THERAPEUTIC AGENTS
GB0805912D0 (en) Treatment
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy
GB0811715D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)